Information de reference pour ce titreAccession Number: | 00054821-201310000-00005.
|
Author: | Bugnicourt, J.-M. 1,2,3; Flament, M. 1,2; Guillaumont, M.-P. 4; Chillon, J.-M. 3,5; Leclercq, C. 1,2; Canaple, S. 1; Lamy, C. 1; Godefroy, O. 1,2
|
Institution: | (1)Department of Neurology, Amiens University Hospital, Amiens, France (2)Laboratory of Functional Neurosciences and Pathology (EA 4559), Amiens, France (3)INSERM U1088, Amiens, France (4)Department of Cardiology, Amiens University Hospital, Amiens, France (5)University of Picardie Jules Verne, Amiens, France
|
Title: | Predictors of newly diagnosed atrial fibrillation in cryptogenic stroke: a cohort study.[Article]
|
Source: | European Journal of Neurology. 20(10):1352-1359, October 2013.
|
Abstract: | Background and purpose: A significant proportion of cryptogenic ischaemic strokes are due to paroxysmal atrial fibrillation (AF). As paroxysmal AF appears to inexorably progress to persistent or permanent AF, this study with long-term follow-up was designed to establish the profile of patients who developed AF after hospital discharge.
Methods: All patients with cryptogenic ischaemic stroke over a 1-year period were included (n = 164). Patients were prospectively followed up at the outpatient clinic. Information on long-term outcome included the presence of newly diagnosed AF (NDAF). A specific NDAF assessment was performed at least 2 years after the index stroke using a structured telephone interview. Baseline clinical, laboratory, and echocardiographic data of these patients were retrospectively recorded. Independent predictive factors were then used to produce a predictive grading score for NDAF, derived by logistic regression analysis.
Results: With a median follow-up of 854 days, 22 cases of NDAF (13%) were observed. On multivariate analysis, factors associated with NDAF were age >=72 years (two points), history of coronary artery disease (one point) or stroke (one point), and left atrial area >=16 cm2 (two points) (total score ranging from 0 to 6). Patients with a score <=1 point did not have NDAF during follow-up.
Conclusions: In cryptogenic ischaemic stroke, the NDAF score can be used to target patients at high risk of developing AF after hospital discharge, as a score of 0-1 was highly predictive of the absence of NDAF during follow-up. These results need to be confirmed in prospective studies.
(C) 2013 John Wiley & Sons, Ltd
|
Author Keywords: | atrial fibrillation; ischaemic stroke; outcome; secondary prevention.
|
References: | Lip GY, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res, 2006; 118: 321-333.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke, 1991; 22: 983-988.
Hart RG, Pearce LA, Miller VT, et al. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis, 2000; 10: 39-43.
Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J, 2007; 28: 2803-2817.
Kimura K, Minematsu K, Kazui S, Yamaguchi T. Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc Dis, 2005; 19: 171-178.
Mattle HP. Long-term outcome after stroke due to atrial fibrillation. Cerebrovasc Dis, 2003; 16: 3-8.
Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2011; 42: 227-276.
European Stroke Organisation (ESO) Executive Committee; ESO writing committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis, 2008; 25: 457-507.
Adams HP Jr. Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993; 24: 35-41.
Seet RC, Friedman PA, Rabinstein AA. Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation, 2011; 124: 477-486.
Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J, 2010; 31: 2369-2429.
Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis, 2009; 27: 502-508.
Bugnicourt JM, Chillon JM, Canaple S, Lamy C, Godefroy O. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy. Fundam Clin Pharmacol, 2008; 22: 217-222.
Morris JG, Duffis EJ, Fisher M. Cardiac workup of ischemic stroke: can we improve our diagnostic yield? Stroke, 2009; 40: 2893-2898.
Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Int Med, 2003; 139: 137-147.
Kasner SE, Chalela JA, Luciano JM, et al. Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke, 1999; 30: 1534-1537.
Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet, 1991; 337: 1521-1526.
Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr, 2009; 22: 107-133.
Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines: developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006; 114: e257-e354.
Kamel H, Hegde M, Johnson DR, Gage BF, Johnston SC. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke, 2010; 41: 1514-1520.
Schaer BA, Zellweger MJ, Cron TA, Kaiser CA, Osswald S. Value of routine Holter monitoring for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemic events. Stroke, 2004; 35: e68-e70.
Kamel H, Lees KR, Lyden PD, et al. Delayed detection of atrial fibrillation after ischemic stroke. J Stroke CerebroVasc Dis, 2009; 18: 453-457.
Kamel H, Johnson DR, Hegde M, et al. Detection of atrial fibrillation after stroke and the risk of recurrent stroke. J Stroke Cerebrovasc Dis, 2011. [Epub ahead of print].
Malik S, Hicks WJ, Schultz L, et al. Development of a scoring system for atrial fibrillation in acute stroke and transient ischemic attack patients: the LADS scoring system. J Neurol Sci, 2011; 301: 27-30.
Barthelemy JC, Feasson-Gerard S, Garnier P, et al. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol, 2003; 8: 194-199.
Dion F, Saudeau D, Bonnaud I, et al. Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study. J Interv Card Electrophysiol, 2010; 28: 101-107.
Elijovich L, Josephson SA, Fung GL, Smith WS. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis, 2009; 18: 185-189.
Gaillard N, Deltour S, Vilotijevic B, et al. Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients. Neurology, 2010; 74: 1666-1670.
Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke, 2004; 35: 1647-1651.
Rizos T, Rasch C, Jenetzky E, et al. Detection of paroxysmal atrial fibrillation in acute stroke patients. Cerebrovasc Dis, 2010; 30: 410-417.
Schuchert A, Behrens G, Meinertz T. Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke. Pacing Clin Electrophysiol, 1999; 22: 1082-1084.
Tayal AH, Tian M, Kelly KM, et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology, 2008; 71: 1696-1701.
Sinha AM, Diener HC, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation (CRYSTAL AF): design and rationale. Am Heart J, 2010; 160: 36-41.
Bansil S, Karim H. Detection of atrial fibrillation in patients with acute stroke. J Stroke Cerebrovasc Dis, 2004; 13: 12-15.
Sposato LA, Klein FR, Jauregui A, et al. Newly diagnosed atrial fibrillation after acute ischemic stroke and transient ischemic attack: importance of immediate and prolonged continuous cardiac monitoring. J Stroke Cerebrovasc Dis, 2010; 21: 210-216.
Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent Holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis, 2012; 21: 89-93.
Dangayach NS, Kane K, Moonis M. Paroxysmal atrial fibrillation in cryptogenic stroke. Ther Clin Risk Manag, 2011; 7: 33-37.
Doliwa Sobocinski P, Anggardh Rooth E, Frykman Kull V, von Arbin M, Wallen H, Rosenqvist M. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace, 2012; 14: 1112-1116.
Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 1997; 96: 2455-2461.
Suissa L, Bertora D, Lachaud S, Mahagne MH. Score for the targeting of atrial fibrillation (STAF): a new approach to the detection of atrial fibrillation in the secondary prevention of ischemic stroke. Stroke, 2009; 40: 2866-2868.
Parvez B, Darbar D. The 'missing' link in atrial fibrillation heritability. J Electrocardiol, 2011; 44: 641-644.
Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med, 2012; 366: 120-129.
Rosenberg MA, Gottdiener JS, Heckbert SR, Mukamal KJ. Echocardiographic diastolic parameters and risk of atrial fibrillation: the cardiovascular health study. Eur Heart J, 2012; 33: 904-912.
Acevedo M, Corbalan R, Braun S, Pereira J, Navarrete C, Gonzalez I. C-reactive protein and atrial fibrillation: 'Evidence for the presence of inflammation in the perpetuation of the arrhythmia'. Int J Cardiol, 2006; 108: 326-331.
|
Language: | English.
|
Document Type: | Original Articles.
|
Journal Subset: | Clinical Medicine. Life & Biomedical Sciences.
|
ISSN: | 1351-5101
|
NLM Journal Code: | daf, 9506311
|
DOI Number: | https://dx.doi.org/10.1111/ene.1...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|